New Key Statistics Module, Z-Score and F-Score
NAS:OVID Key Ratios
Market Cap $ M | 85.88 |
Enterprise Value $ M | 24.29 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.96 |
Price/Sales | 150.00 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.43 |
Beneish M-Score | -1.06 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.35 |
EV-to-EBITDA | -0.35 |
PEG | -- |
Shares Outstanding M | 70.97 |
Net Margin (%) | -5,237.15 |
Operating Margin % | -11,998.59 |
Pre-tax Margin (%) | -5,237.15 |
Quick Ratio | 5.73 |
Current Ratio | 5.73 |
ROA % (ttm) | -22.71 |
ROE % (ttm) | -31.85 |
ROIC % (ttm) | -185.78 |
Dividend Yield % | -- |
Altman Z-Score | -1.73 |
OVID Number of Guru Trades
OVID Volume of Guru Trades
Gurus Latest Trades with NAS:OVID
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:OVID is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Ovid Therapeutics Inc Insider Transactions
No Available Data
News about NAS:OVID
Total 0- 1